Journal of Shandong University (Health Sciences) ›› 2019, Vol. 57 ›› Issue (1): 81-86.doi: 10.6040/j.issn.1671-7554.0.2018.652

Previous Articles    

Risk factors and treatment of hemorrhage after pancreatoduodenectomy

WANG Chunming, LIU Qincheng, GUO Linghong, LIAO Caixian   

  1. Department of Hepatobiliary Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong, China
  • Published:2022-09-27

Abstract: Objective To explore the risk factors and treatment strategies of postpancreatoduodenectomy hemorrhage(PPH). Methods The clinical data of 424 patients who underwent pancreatoduodenectomy(PD)during Jan. 1, 2005 and Dec. 31, 2017 were retrospectively analyzed to evaluate the risk factors and treatment strategies of the occurrence of PPH. The chi-square test and logistic regression were used for univariate and multivariate analyses. Results PPH occurred in 60 patients, 9 of whom died, and the mortality was 2.12%(9/424). Of these 9 patients, 6 died due to hemorrhage. Univariate analysis showed that complications such as hypertension, pancreatic fistula, biliary fistula, and intra-abdominal infection were related risk factors of PPH(χ2=7.832, 28.491, 7.086, 25.378, respectively, P<0.05). Logistic multivariate analysis showed that complications such as hypertension, intra-abdominal infection and pancreatic fistula were independent risk factors of PPH(OR=2.242,3.068, 2.953, respectively, 95%CI=1.169-4.300, 1.501-6.274, 1.491-5.849, respectively, P<0.05). Conclusion Complicated hypertension, pancreatic fistula, and intra-abdominal infection are the independent risk factors of PPH. The keys to prevent PPH are to maintain stable blood pressure, reduce pancreatic fistula and intra-abdominal infection perioperatively. In case of PPH, the choice of treatment strategies should be determined according to the onset, location and severity of hemorrhage.

Key words: Pancreatoduodenectomy, Postoperative hemorrhage, Risk factor, Treatment

CLC Number: 

  • R619+.1
[1] Aoki S, Miyata H, Konno H, et al. Risk factors of serious postoperative complications after pancreaticoduodenectomy and risk calculators for predicting postoperative complications: a nationwide study of 17,564 patients in Japan [J]. J Hepatobiliary Pancreat Sci, 2017, 24(5): 243-251.
[2] Gao F, Li J, Quan S, et al. Risk factors and treatment for hemorrhage after pancreaticoduodenectomy: a case series of 423 patients[J]. Biomed Res Int, 2016, 2016: 2815693.
[3] 中华医学会外科学分会胰腺外科学组, 中国研究型医院学会胰腺病专业委员会, 中华外科杂志编辑部. 胰腺术后外科常见并发症诊治及预防的专家共识(2017)[J]. 中华外科杂志, 2017, 55(5): 328-334. Study Group of Pancreatic Surgery in Chinese Society of Surgery of Chinese Medical Association, Pancreatic Disease Committee of Chinese Research Hospital Association, Editorial Board of Chinese Journal of Surgery. A consensus statement on the diagnosis, treatment, and prevention of common complications after pancreatic surgery(2017)[J]. Chinese Journal of Surgery, 2017, 55(5): 328-334.
[4] Moritz N Wente, Johannes A Veit, Claudio Bassi, et al. Postpancreatectomy hemorrhage(PPH)-an international study group of pancreatic surgery(ISGPS)definition[J]. Surgery, 2007, 142(1): 20-25.
[5] Bassi C, Marchegiani G, Dervenis C, et al. The 2016 update of the international study group(ISGPS)definition and grading of postoperative pancreatic fistula: 11 Years After[J]. Surgery, 2017, 161(3): 584-591.
[6] Correa-Gallego C, Brennan MF, D'Angelica MI, et al. Contemporary experience with postpancreatectomy hemorrhage: results of 1,122 patients resected between 2006 and 2011[J]. J Am Coll Surg, 2012, 215(5): 616-621.
[7] Khalsa BS, Imagawa DK, Chen JI, et al. Evolution in the treatment of delayed postpancreatectomy hemorrhage: surgery to interventional radiology[J]. Pancreas, 2015, 44(6): 953-958.
[8] Koukoutsis I, Bellagamba R, Morris-Stiff G, et al. Haemorrhage following pancreaticoduodenectomy: risk factors and the importance of sentinel bleed[J]. Dig Surg, 2006, 23(4): 224-228.
[9] Feng J, Chen YL, Dong JH, et al. Post-pancreaticoduodenectomy hemorrhage: risk factors, managements and outcomes [J]. Hepatobiliary Pancreat Dis Int, 2014, 13(5): 513-522.
[10] Darnis B, Lebeau R, Chopin-Laly X, et al. Postpancreatectomy hemorrhage(PPH): predictors and management from a prospective database[J]. Langenbecks Arch Surg, 2013, 398(3): 441-448.
[11] Kasumova GG, Eskander MF, Kent TS, et al. Hemorrhage after pancreaticoduodenectomy: does timing matter? [J]. HPB(Oxford), 2016, 18(10): 861-869.
[12] Nakahara O, Takamori H, Ikeda O, et al. Risk factors associated with delayed haemorrhage after pancreatic resection[J]. HPB(Oxford), 2012, 14(10): 684-687.
[13] Gaudon C, Soussan J, Louis G, et al. Late postpancreatectomy hemorrhage: predictive factors of morbidity and mortality after percutaneous endovascular treatment[J]. Diagn Interv Imaging, 2016, 97(11): 1071-1077.
[14] 中国高血压防治指南修订委员会. 中国高血压防治指南2010[J]. 中华心血管病杂志, 2011, 39(7): 579-616. The rebision committee for Chinas prevention and cure guide of hypertension. 2010 Chinese guidelines for the management of hypertension [J]. Chinese Journal of Cardiology, 2011, 39(7): 579-616.
[15] Liu QY, Zhang WZ, Xia HT, et al. Analysis of risk factors for postoperative pancreatic fistula following pancreaticoduodenectomy[J]. World J Gastroenterol, 2014, 20(46): 17491-17497.
[16] Hu BY, Wan T, Zhang WZ, et al. Risk factors for postoperative pancreatic fistula: analysis of 539 successive cases of pancreaticoduodenectomy [J]. World J Gastroenterol, 2016, 22(34): 7797-7805.
[17] Addeo P, Delpero JR, Paye F, et al. Pancreatic fistula after a pancreaticoduodenectomy for ductal adenocarcinoma and its association with morbidity: a multicenter study of the French Surgical Association [J]. HPB(Oxford), 2014, 16(1): 46-55.
[18] Wellner UF, Kulemann B, Lapshyn H, et al. Postpancreatectomy hemorrhage—incidence, treatment, and risk Factors in over 1,000 pancreatic resections[J]. J Gastrointest Surg, 2014, 18(3): 464-475.
[19] Ricci C, Casadei R, Buscemi S, et al. Late postpancreatectomy hemorrhage after pancreaticoduodenectomy: is it possible to recognize risk factors? [J]. JOP, 2012, 13(2): 193-198.
[20] Tien YW, Lee PH, Yang CY, et al. Risk factors of massive bleeding related to pancreatic leak after pancreaticoduodenectomy[J]. J Am Coll Surg, 2005, 201(4): 554-559.
[21] Zhou TY, Sun JH, Zhang YL, et al. Post-pancreaticoduodenectomy hemorrhage: DSA diagnosis and endovascular treatment[J]. Oncotarget, 2017, 8(43): 73684-73692.
[22] Yekebas EF, Wolfram L, Cataldegirmen G, et al. Postpancreatectomy hemorrhage: diagnosis and treatment: an analysis in 1 669 consecutive pancreatic resections[J]. Ann Surg, 2007, 246(2): 269-280.
[23] 张太平, 徐建威, 赵玉沛. 胰腺癌根治术常见并发症与处理原则[J]. 中华普外科手术学杂志电子版, 2013, 7(3): 172-175. ZHANG Taiping, XU Jianwei, ZHAO Yupei. Post-operative complications after radical resection for pancreatic cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2013, 7(3): 172-175.
[24] 王正堂, 林海, 王勇, 等. 胰十二指肠切除术后晚期出血的诊断与治疗[J]. 中华消化外科杂志, 2014, 13(4): 277-280. WANG Zhengtang, LIN Hai, WANG Yong, et al. Diagnosis and treatment of delayed postoperative hemorrhage after pancreaticoduodenectomy[J]. Chinese Journal of Digestive Surgery, 2014, 13(4): 277-280.
[25] Limongelli P, Khorsandi SE, Pai M, et al. Management of delayed postoperative hemorrhage after pancreaticoduodenectomy: a meta-analysis[J]. Arch Surg, 2008, 143(10): 1001-1007.
[1] JIANG Ziqing, ZENG Yanping, JI Xiaodong, ZUO Junling. A case report of hemophagocytic syndrome secondary to talaromyces marneffei infection [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 91-97.
[2] Chao PENG,Yingfang ZHOU. Progress on the medical treatment of adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 20-25.
[3] YAO Xue, LU Ranran, SUN Shuling, GAO Cuiping, XIAO Ru, WANG Shuhui. Establishment of a risk prediction scoring model for nosocomial infection in rheumatic heart disease patients after valve replacement surgery [J]. Journal of Shandong University (Health Sciences), 2022, 60(6): 90-96.
[4] YANG Congpin, LUO Zhuoye, XU Xiuhua, LI Aimin, HAO Guimin. Reproductive choices and pressure in 3,512 women of childbearing age in a hospital in Hebei Province [J]. Journal of Shandong University (Health Sciences), 2022, 60(4): 62-67.
[5] KONG Xinxin, SUN Shuzhen, LI Qian, CHEN Yuan, ZHOU Aihua, WANG Li, YAO Xiujun. Analysis of 7 cases of anti-H factor antibody-positive hemolytic uremic syndrome [J]. Journal of Shandong University (Health Sciences), 2022, 60(4): 82-86.
[6] SONG Yufeng, NING Hao, YAO Zhigang, WU Haihu, LIU Feifan, LYU Jiaju. Clinical and imaging features of adrenal cavernous hemangioma [J]. Journal of Shandong University (Health Sciences), 2022, 60(2): 37-42.
[7] LYU Yanhong, ZHANG Zhimian. Correlation of helicobacter pylori infection and hypertension in the 2,809 physical examination participants [J]. Journal of Shandong University (Health Sciences), 2022, 60(2): 43-47.
[8] PAN Pengfei, XU Lisheng, JI Kunqian, WANG Dexiang, LI Yu. Mitochondrial myopathy beginning with respiratory failure: one case and literature review [J]. Journal of Shandong University (Health Sciences), 2022, 60(2): 54-59.
[9] Yifeng WANG,Liqing HE. Research progress on surgery of inguinal lymph nodes in vulvar cancer [J]. Journal of Shandong University (Health Sciences), 2021, 59(9): 103-109,116.
[10] Chunfang HA,Ruyue LI. Research progress of drug resistance in ovarian cancer and targeted therapy strategy [J]. Journal of Shandong University (Health Sciences), 2021, 59(9): 117-123.
[11] Kefang WANG,Chen WU. Dilemmas and thoughts on solutions of adherence to chronic disease management [J]. Journal of Shandong University (Health Sciences), 2021, 59(9): 124-129.
[12] WANG Zhe, LIU Yujie, MAO Qian, GUAN Peixia, BAO Qihan, LI Chengsheng, QIAO Xiaowei, PAN Qingzhong, WANG Suzhen. Evaluation of the efficacy of different regimens for early triple negative breast cancer based on the inverse probability of treatment weighting method [J]. Journal of Shandong University (Health Sciences), 2021, 59(8): 113-118.
[13] CHEN Liyu, XIAO Juan, LYU Xianzhong, DUAN Baomin, HONG Fanzhen. Risk factors influencing prognosis of lower extremity deep vein thrombosis in pregnant and parturient women [J]. Journal of Shandong University (Health Sciences), 2021, 59(7): 38-42.
[14] Haipeng SI,Wencan ZHANG,Le LI,Xin ZHOU. Research advances on risk factors, diagnosis and treatment of Kümmell's disease [J]. Journal of Shandong University (Health Sciences), 2021, 59(6): 25-32.
[15] ZENG Rong, WU Jinxiang, ZHANG Jintao, SHANGGUAN Hong, ZHOU Shengyu, TIAN Tian, DONG Liang. Primary pulmonary angiosarcoma: a case report and literature review [J]. Journal of Shandong University (Health Sciences), 2021, 59(2): 19-25.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!